Caroline Sychterz

Caroline is Director at Bristol Myers Squibb, leading the application of physiologically based pharmacokinetic (PBPK) modeling to support clinical development and regulatory decision-making. She has more than 25 years of experience in drug metabolism, pharmacokinetics, and quantitative modeling, with a strong track record of advancing model-informed drug development across discovery and clinical programmes.